Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Anderer

Showing results (21-30 of 108) with videos related to

Pageof 11
Sort By:
Schizophrenia Research|August 24, 2001
Impaired conditional discrimination learning in schizophreniaE Hofer, D Doby, P Anderer, et al.
Wiener Klinische Wochenschrift|June 1, 2001
Activity monitoring in sleep research, medicine and psychopharmacologyG Klösch, G Gruber, P Anderer, et al.
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1990
Brain protection of nicergoline against hypoxia: EEG brain mapping and psychometryB Saletu, J Grünberger, L Linzmayer, et al.
Methods and Findings in Experimental and Clinical Pharmacology|January 1, 1996
Effects of the novel neuroprotective agent, riluzole, on human brain function and behavior: I. Double-blind, placebo-controlled EEG mapping and psychometric studies under normoxiaB Saletu, J Grünberger, P Anderer, et al.
Pharmacopsychiatry|February 1, 1987
Comparative placebo-controlled pharmacodynamic studies with zotepine and clozapine utilizing pharmaco-EEG and psychometryB Saletu, J Grünberger, L Linzmayer, et al.
Pharmacopsychiatry|September 1, 1987
Contralateral eye movements and alpha reactivity of lithium patients in recognition tasksE Opgenoorth, R Wolf, O Presslich, et al.
Neuropsychobiology|January 1, 1990
Topographic mapping of cognitive event-related potentials in a double-blind, placebo-controlled study with the hemoderivative Actovegin in age-associated memory impairmentH V Semlitsch, P Anderer, B Saletu, et al.
Psychophysiology|November 1, 1986
A solution for reliable and valid reduction of ocular artifacts, applied to the P300 ERPH V Semlitsch, P Anderer, P Schuster, et al.
British Journal of Clinical Pharmacology|February 1, 1996
On the cerebro-protective effects of caroverine, a calcium-channel blocker and antiglutamatergic drug: double-blind, placebo-controlled, EEG mapping and psychometric studies under hypoxiaB Saletu, J Grünberger, P Anderer, et al.
Neuropsychobiology|January 1, 1993
Restriction to a limited set of EEG-target variables may lead to misinterpretation of pharmaco-EEG resultsP Anderer, M J Barbanoj, B Saletu, et al.
Pageof 11

Showing results (21-30 of 108) with videos related to

Sort By:
Pageof 11
Schizophrenia Research|August 24, 2001
Impaired conditional discrimination learning in schizophreniaE Hofer, D Doby, P Anderer, et al.
Wiener Klinische Wochenschrift|June 1, 2001
Activity monitoring in sleep research, medicine and psychopharmacologyG Klösch, G Gruber, P Anderer, et al.
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1990
Brain protection of nicergoline against hypoxia: EEG brain mapping and psychometryB Saletu, J Grünberger, L Linzmayer, et al.
Methods and Findings in Experimental and Clinical Pharmacology|January 1, 1996
Effects of the novel neuroprotective agent, riluzole, on human brain function and behavior: I. Double-blind, placebo-controlled EEG mapping and psychometric studies under normoxiaB Saletu, J Grünberger, P Anderer, et al.
Pharmacopsychiatry|February 1, 1987
Comparative placebo-controlled pharmacodynamic studies with zotepine and clozapine utilizing pharmaco-EEG and psychometryB Saletu, J Grünberger, L Linzmayer, et al.
Pharmacopsychiatry|September 1, 1987
Contralateral eye movements and alpha reactivity of lithium patients in recognition tasksE Opgenoorth, R Wolf, O Presslich, et al.
Neuropsychobiology|January 1, 1990
Topographic mapping of cognitive event-related potentials in a double-blind, placebo-controlled study with the hemoderivative Actovegin in age-associated memory impairmentH V Semlitsch, P Anderer, B Saletu, et al.
Psychophysiology|November 1, 1986
A solution for reliable and valid reduction of ocular artifacts, applied to the P300 ERPH V Semlitsch, P Anderer, P Schuster, et al.
British Journal of Clinical Pharmacology|February 1, 1996
On the cerebro-protective effects of caroverine, a calcium-channel blocker and antiglutamatergic drug: double-blind, placebo-controlled, EEG mapping and psychometric studies under hypoxiaB Saletu, J Grünberger, P Anderer, et al.
Neuropsychobiology|January 1, 1993
Restriction to a limited set of EEG-target variables may lead to misinterpretation of pharmaco-EEG resultsP Anderer, M J Barbanoj, B Saletu, et al.
Pageof 11